Bliss GVS Pharma

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue181.93169.23172.28155.80191.00
Expenses135.87140.71146.43129.65167.11
EBITDA52.9236.5633.6133.5833.73
EBIT47.2530.31-13.7027.3227.34
Profit Before Tax46.0728.52-15.2326.1523.89
Net Profit33.8920.72-11.4619.4217.04
Financial Ratios
Operating Profit Margin30.89%22.66%-4.56%22.54%18.47%
Net Profit Margin19.78%12.84%14.43%13.04%9.33%
Earning Per Share (Diluted)3.191.95-1.081.811.63
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ